Notice2022-01345
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 25, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on March 8, 2022. The topic for this meeting will be "Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research." The meeting is open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 16 (Tuesday, January 25, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 16 (Tuesday, January 25, 2022)]
[Notices]
[Page 3830]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01345]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on March 8, 2022. The topic for this
meeting will be ``Opportunities for Research Supported by the Special
Statutory Funding Program for Type 1 Diabetes Research.'' The meeting
is open to the public.
DATES: The meeting will be held on March 8, 2022 from 8:30 a.m. to 4:45
p.m. EDT.
ADDRESSES: The meeting will be held via an online video conferencing
platform. Virtual attendance for the meeting will be accessible to
members of the public who register at <a href="https://www.scgcorp.com/dmicc2022/Registration">https://www.scgcorp.com/dmicc2022/Registration</a> at least 5 days prior to the workshop.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, which will be posted when
available, see the DMICC website, <a href="http://www.diabetescommittee.gov">www.diabetescommittee.gov</a>, or contact
Dr. William Cefalu, Director, Division of Diabetes, Endocrinology, and
Metabolic Diseases, National Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy Boulevard, Democracy 2, Room 6037,
Bethesda, MD 20892, telephone: 301-435-1011; email: <a href="/cdn-cgi/l/email-protection#d6b2bbbfb5b596bbb7bfbaf8b8bfbef8b1b9a0"><span class="__cf_email__" data-cfemail="0e6a63676d6d4e636f67622060676620696178">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S.C. 285c-3, the
DMICC, chaired by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) and comprising members of the Department of
Health and Human Services and other federal agencies that support
diabetes-related activities, facilitates cooperation, communication,
and collaboration on diabetes among government entities. DMICC
meetings, held several times a year, provide an opportunity for
Committee members to learn about and discuss current and future
diabetes programs in DMICC member organizations and to identify
opportunities for collaboration. The March 8, 2022 DMICC meeting will
focus on ``Opportunities for Research Supported by the Special
Statutory Funding Program for Type 1 Diabetes Research.'' Any
interested person may file written comments with the Committee by
forwarding their statement to the contact person listed on this notice.
The statement should include the name, address, telephone number and,
when applicable, the business or professional affiliation of the
interested person. Because of time constraints for the meeting, there
will not be time on the agenda for oral comments from members of the
public.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, <a href="http://www.diabetescommittee.gov">www.diabetescommittee.gov</a>.
Dated: January 19, 2022.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2022-01345 Filed 1-24-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 25, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.